HEALTH
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
![High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer](https://connecticutnewspress.com/wp-content/uploads/2024/05/7817-high-response-rates-with-gene-therapies-for-bcg-unresponsive-bladder-cancer-780x470.jpg)
MedPage Today) — SAN ANTONIO — More than 70% of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) achieved complete responses to a novel gene therapy, a small preliminary trial showed.
Across a range of doses, 16 of…